In Frequency Therapeutics’ short lifetime as a company, it’s had its ups and downs. On Tuesday, during an R&D event day, the company unleashed a slew of announcements that add context to the development of a flagship hearing loss drug, and proposed some directions.  Founded in 2015, Frequency Therapeutics has focused on a regenerative medicine … Continue reading Frequency Therapeutics redesigns study after disappointing Phase 2 results, debuts new hearing loss and MS drugs